right
targets

right
molecules

right
indications

right
endpoints

right
patients

Transform Therapies, Reimagine Lives.

Transforming the lives of patients living with immune-mediated diseases using a precision approach to develop oral therapies.

About Alumis

Our Pipeline

We strive to transform the treatment paradigm for people living with immune-mediated diseases by replacing broad immunosuppression with targeted therapies. We are developing a pipeline of novel oral drug candidates with the potential to address a broad range of immune-mediated diseases.

Our Pipeline

Our Approach

We are pioneering a precision approach to develop next-generation therapies designed to address immune dysfunction. Our driving principle is to deliver the right medicine to achieve the best possible clinical outcome. To realize that goal, we apply our precision approach to immunology by focusing on the important drivers of immune dysfunction while relying on key genetic and translational insights, to optimize therapeutic outcomes for patients.

Our Approach

Our Clinical Programs

Addressing the needs of patients living with immune-mediated diseases is why we exist. Despite recent advances in treatment, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. We are developing next-generation treatments for immune-mediated diseases with a goal of significantly improving clinical outcomes for patients.

Clinical Programs